Linked Life Data

11728425

Source:http://linkedlifedata.com/resource/pubmed/id/11728425

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11728425rdf:typepubmed:Citationlld:pubmed
pubmed-article:11728425lifeskim:mentionsumls-concept:C0003064lld:lifeskim
pubmed-article:11728425lifeskim:mentionsumls-concept:C0001041lld:lifeskim
pubmed-article:11728425lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:11728425lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:11728425lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:11728425lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:11728425lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:11728425lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:11728425lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:11728425lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:11728425lifeskim:mentionsumls-concept:C1516691lld:lifeskim
pubmed-article:11728425lifeskim:mentionsumls-concept:C0764687lld:lifeskim
pubmed-article:11728425lifeskim:mentionsumls-concept:C1627358lld:lifeskim
pubmed-article:11728425pubmed:issue2lld:pubmed
pubmed-article:11728425pubmed:dateCreated2001-11-30lld:pubmed
pubmed-article:11728425pubmed:abstractTextThe present studies were designed to assess whether the novel muscarinic M(2) receptor antagonist 4-cyclohexyl-alpha-[4[[4-methoxyphenyl]sulphinyl]-phenyl]-1-piperazineacetonitrile (SCH 57790) could increase acetylcholine release in the central nervous system (CNS) and enhance cognitive performance in rodents and nonhuman primates. In vivo microdialysis studies show that SCH 57790 (0.1-10 mg/kg, p.o.) produced dose-related increases in acetylcholine release from rat hippocampus, cortex, and striatum. SCH 57790 (0.003-1.0 mg/kg) increased retention times in young rat passive avoidance responding when given either before or after training. Also, SCH 57790 reversed scopolamine-induced deficits in mice in a passive avoidance task. In a working memory operant task in squirrel monkeys, administration of SCH 57790 (0.01-0.03 mg/kg) improved performance under a schedule of fixed-ratio discrimination with titrating delay. The effects observed with SCH 57790 in behavioral studies were qualitatively similar to the effects produced by the clinically used cholinesterase inhibitor donepezil, suggesting that blockade of muscarinic M(2) receptors is a viable approach to enhancing cognitive performance.lld:pubmed
pubmed-article:11728425pubmed:languageenglld:pubmed
pubmed-article:11728425pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11728425pubmed:citationSubsetIMlld:pubmed
pubmed-article:11728425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11728425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11728425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11728425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11728425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11728425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11728425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11728425pubmed:statusMEDLINElld:pubmed
pubmed-article:11728425pubmed:monthNovlld:pubmed
pubmed-article:11728425pubmed:issn0014-2999lld:pubmed
pubmed-article:11728425pubmed:authorpubmed-author:WatkinsR WRWlld:pubmed
pubmed-article:11728425pubmed:authorpubmed-author:CrosbyGGlld:pubmed
pubmed-article:11728425pubmed:authorpubmed-author:CoffinV LVLlld:pubmed
pubmed-article:11728425pubmed:authorpubmed-author:CareyG JGJlld:pubmed
pubmed-article:11728425pubmed:authorpubmed-author:GuzikHHlld:pubmed
pubmed-article:11728425pubmed:authorpubmed-author:KozlowskiJ...lld:pubmed
pubmed-article:11728425pubmed:authorpubmed-author:TedescoR PRPlld:pubmed
pubmed-article:11728425pubmed:authorpubmed-author:BillardWWlld:pubmed
pubmed-article:11728425pubmed:authorpubmed-author:OWENFFlld:pubmed
pubmed-article:11728425pubmed:authorpubmed-author:BinchHH3rdlld:pubmed
pubmed-article:11728425pubmed:authorpubmed-author:Cohen-William...lld:pubmed
pubmed-article:11728425pubmed:authorpubmed-author:GrzelakMMlld:pubmed
pubmed-article:11728425pubmed:authorpubmed-author:PondA JAJlld:pubmed
pubmed-article:11728425pubmed:issnTypePrintlld:pubmed
pubmed-article:11728425pubmed:day16lld:pubmed
pubmed-article:11728425pubmed:volume431lld:pubmed
pubmed-article:11728425pubmed:ownerNLMlld:pubmed
pubmed-article:11728425pubmed:authorsCompleteYlld:pubmed
pubmed-article:11728425pubmed:pagination189-200lld:pubmed
pubmed-article:11728425pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:meshHeadingpubmed-meshheading:11728425...lld:pubmed
pubmed-article:11728425pubmed:year2001lld:pubmed
pubmed-article:11728425pubmed:articleTitleSCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals.lld:pubmed
pubmed-article:11728425pubmed:affiliationPharmacia Corp., 301 Henrietta St., Kalamazoo, MI 49007, USA. galen.j.carey@pharmacia.comlld:pubmed
pubmed-article:11728425pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11728425pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11728425lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11728425lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11728425lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11728425lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11728425lld:pubmed